CERS
Price
$1.89
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
15 days until earnings call
NEOG
Price
$14.02
Change
-$0.00 (-0.00%)
Updated
Oct 14 closing price
62 days until earnings call
Ad is loading...

CERS vs NEOG

Header iconCERS vs NEOG Comparison
Open Charts CERS vs NEOGBanner chart's image
Cerus
Price$1.89
Change-$0.00 (-0.00%)
Volume$1.53M
CapitalizationN/A
Neogen
Price$14.02
Change-$0.00 (-0.00%)
Volume$1.9M
CapitalizationN/A
View a ticker or compare two or three
CERS vs NEOG Comparison Chart
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CERS vs. NEOG commentary
Oct 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Hold and NEOG is a Buy.

COMPARISON
Comparison
Oct 16, 2024
Stock price -- (CERS: $1.89 vs. NEOG: $14.02)
Brand notoriety: CERS and NEOG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CERS: 160% vs. NEOG: 131%
Market capitalization -- CERS: $342.62M vs. NEOG: $3.42B
CERS [@Medical Specialties] is valued at $342.62M. NEOG’s [@Medical Specialties] market capitalization is $3.42B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileNEOG’s FA Score has 1 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • NEOG’s FA Score: 1 green, 4 red.
According to our system of comparison, NEOG is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 5 TA indicator(s) are bullish while NEOG’s TA Score has 4 bullish TA indicator(s).

  • CERS’s TA Score: 5 bullish, 4 bearish.
  • NEOG’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CERS is a better buy in the short-term than NEOG.

Price Growth

CERS (@Medical Specialties) experienced а +9.88% price change this week, while NEOG (@Medical Specialties) price change was -5.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

CERS is expected to report earnings on Feb 20, 2025.

NEOG is expected to report earnings on Dec 17, 2024.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEOG($3.42B) has a higher market cap than CERS($343M). CERS YTD gains are higher at: -12.500 vs. NEOG (-30.283). NEOG has higher annual earnings (EBITDA): 189M vs. CERS (-26.34M). NEOG has more cash in the bank: 230M vs. CERS (65.9M). CERS has less debt than NEOG: CERS (96M) vs NEOG (889M). NEOG has higher revenues than CERS: NEOG (919M) vs CERS (156M).
CERSNEOGCERS / NEOG
Capitalization343M3.42B10%
EBITDA-26.34M189M-14%
Gain YTD-12.500-30.28341%
P/E RatioN/A150.80-
Revenue156M919M17%
Total Cash65.9M230M29%
Total Debt96M889M11%
FUNDAMENTALS RATINGS
CERS vs NEOG: Fundamental Ratings
CERS
NEOG
OUTLOOK RATING
1..100
860
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9689
PRICE GROWTH RATING
1..100
5960
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (52) in the Medical Specialties industry is somewhat better than the same rating for NEOG (96). This means that CERS’s stock grew somewhat faster than NEOG’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NEOG (100). This means that CERS’s stock grew similarly to NEOG’s over the last 12 months.

NEOG's SMR Rating (89) in the Medical Specialties industry is in the same range as CERS (96). This means that NEOG’s stock grew similarly to CERS’s over the last 12 months.

CERS's Price Growth Rating (59) in the Medical Specialties industry is in the same range as NEOG (60). This means that CERS’s stock grew similarly to NEOG’s over the last 12 months.

NEOG's P/E Growth Rating (3) in the Medical Specialties industry is significantly better than the same rating for CERS (100). This means that NEOG’s stock grew significantly faster than CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSNEOG
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
47%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
62%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 27 days ago
67%
Declines
ODDS (%)
Bearish Trend 13 days ago
82%
Bearish Trend 8 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
CERS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEOG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X66046.1250003194.750000
+5.08%
Bitcoin cryptocurrency
GME21.330.50
+2.40%
GameStop Corp
AAPL231.403.85
+1.69%
Apple
SPY584.324.74
+0.82%
SPDR® S&P 500® ETF Trust
TSLA219.161.36
+0.62%
Tesla

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with MASS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+3.85%
MASS - CERS
51%
Loosely correlated
+0.14%
FLGT - CERS
48%
Loosely correlated
+2.47%
KIDS - CERS
46%
Loosely correlated
+5.44%
BNGO - CERS
44%
Loosely correlated
-4.94%
BLFS - CERS
44%
Loosely correlated
+3.72%
More

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with CRL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
-2.84%
CRL - NEOG
46%
Loosely correlated
+0.09%
AZTA - NEOG
45%
Loosely correlated
+0.51%
VCYT - NEOG
43%
Loosely correlated
-0.26%
CERS - NEOG
41%
Loosely correlated
+3.85%
ICUI - NEOG
41%
Loosely correlated
+0.97%
More